Vera Therapeutics, Inc. (VERA) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | -1.13M | 0 | 563K | 0 | 0 | 0 | 0 | -952K | -635K | 0 | 0 | -506K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 1.13M | 0 | -563K | 0 | 0 | 0 | 0 | 952K | 635K | 0 | 0 | 506K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | -100% | -100% | - | - | 88.14% | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 125.13M | 95.33M | 83.93M | 79.58M | 57.19M | 48.91M | 49.8M | 37.34M | 32.06M | 27.66M | 21.76M | 21.97M | 31.76M | 33.58M | 25.24M | 15.06M | 17.02M | 16.59M | 7.25M | 5.85M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 39.12M | 34.9M | 27.46M | 21.95M | 15.92M | 15.57M | 9.49M | 8.03M | 7.39M | 5.71M | 5.66M | 5.74M | 6.15M | 6.91M | 5.59M | 4.95M | 4.47M | 3.83M | 3.69M | 2.61M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 86.01M | 59.56M | 56.47M | 58.08M | 41.28M | 33.35M | 40.31M | 29.31M | 24.67M | 21.95M | 16.1M | 16.23M | 25.61M | 26.68M | 19.66M | 10.11M | 12.55M | 12.75M | 3.56M | 3.23M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 879K | 0 | -444K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -125.13M | -94.21M | -83.93M | -80.14M | -57.19M | -48.91M | -49.8M | -37.34M | -31.11M | -27.03M | -21.76M | -21.97M | -31.26M | -33.58M | -25.24M | -15.06M | -17.02M | -16.59M | -7.25M | -5.85M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -118.79% | -92.6% | -68.53% | -114.61% | -83.83% | -80.98% | -128.91% | -69.97% | 0.47% | 19.51% | 13.82% | -45.91% | -83.64% | -102.48% | -248.1% | -157.43% | -260.92% | 61.03% | - | - |
| EBITDA | -125.13M | -94.07M | -83.8M | -79.58M | -57.11M | -48.86M | -49.78M | -35.85M | -32.06M | -27.66M | -21.75M | -21.45M | -31.76M | -33.54M | -24.53M | -14.72M | -17.01M | -16.55M | -7.19M | -5.8M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -119.11% | -92.54% | -68.36% | -121.99% | -78.11% | -76.62% | -128.86% | -67.1% | -0.94% | 17.52% | 11.34% | -45.69% | -86.72% | -102.6% | -241.05% | -153.92% | -263.43% | 61.05% | - | - |
| D&A (Non-Cash Add-back) | 0 | 135K | 129K | 563K | 85K | 55K | 24K | 1.5M | -952K | -635K | 6K | 517K | -506K | 44K | 0 | 0 | 9K | 32K | 59K | 50K |
| EBIT | 0 | -85.47M | -78.33M | -74.66M | -49.9M | -41.55M | -44.7M | -31.8M | -26.48M | -26.53M | -19.16M | -19.25M | -29.2M | -33.58M | -24.53M | -14.72M | -16.97M | -16.83M | -7.61M | -3.44M |
| Net Interest Income | 0 | 13.34M | 3.78M | 4.45M | 5.11M | 4.79M | 2.83M | 3.19M | 2.28M | 904K | 1.22M | 1.32M | 749K | 295K | 420K | 135K | -92K | -14K | 5K | 2K |
| Interest Income | 6.36M | 18.96M | 5.74M | 6.32M | 6.91M | 6.66M | 4.76M | 5.1M | 4.19M | 1.96M | 2.16M | 2.24M | 1.62M | 894K | 567K | 263K | 26K | 6K | 5K | 2K |
| Interest Expense | -1.82M | 5.63M | 1.96M | 1.87M | 1.79M | 1.87M | 1.94M | 1.91M | 1.91M | 1.06M | 943K | 914K | 874K | 599K | 147K | 128K | 118K | 20K | 0 | 0 |
| Other Income/Expense | 4.1M | 3.11M | 3.64M | 3.61M | 5.5M | 5.49M | 3.17M | 3.63M | 2.73M | 1.37M | 1.65M | 1.81M | 1.19M | 1.14M | 565K | 204K | -64K | -261K | -359K | 2.41M |
| Pretax Income | -121.03M | -91.1M | -80.29M | -76.53M | -51.69M | -43.42M | -46.63M | -33.71M | -28.38M | -25.65M | -20.1M | -20.16M | -30.07M | -32.44M | -24.68M | -14.85M | -17.09M | -16.85M | -7.61M | -3.44M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | -1K | 0 | 0 | 0 | 1K | 0 | 0 | 0 | 1K | 0 | 0 | 0 | 1K | 0 | 0 | 0 | 1K | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | -0% | 0% | 0% | 0% | -0% | 0% | 0% | 0% | -0% | 0% | 0% | 0% | -0.01% | 0% | 0% |
| Net Income | -121.03M | -91.1M | -80.29M | -76.53M | -51.69M | -43.42M | -46.63M | -33.71M | -28.38M | -25.66M | -20.1M | -20.16M | -30.07M | -32.44M | -24.68M | -14.85M | -17.09M | -16.85M | -7.61M | -3.44M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -134.13% | -109.78% | -72.18% | -127.04% | -82.13% | -69.27% | -131.95% | -67.19% | 5.61% | 20.91% | 18.54% | -35.74% | -76% | -92.55% | -224.25% | -332.15% | -262.43% | 60.71% | - | - |
| Net Income (Continuing) | -121.03M | -91.1M | -80.29M | -76.53M | -51.69M | -43.42M | -46.63M | -33.71M | -28.38M | -25.66M | -20.1M | -20.16M | -30.07M | -32.44M | -24.68M | -14.85M | -17.09M | -16.85M | -7.61M | -3.44M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.69 | -1.39 | -1.26 | -1.20 | -0.81 | -0.85 | -0.85 | -0.62 | -0.56 | -0.58 | -0.45 | -0.46 | -0.79 | -1.17 | -0.89 | -0.55 | -0.71 | -0.79 | -0.36 | -0.33 |
| EPS Growth % | -108.64% | -63.53% | -48.24% | -93.55% | -44.64% | -46.55% | -88.89% | -34.78% | 29.11% | 50.43% | 49.44% | 16.36% | -11.27% | -48.1% | -147.22% | -66.67% | -208.7% | 62.2% | - | - |
| EPS (Basic) | -1.69 | -1.39 | -1.26 | -1.20 | -0.81 | -0.85 | -0.85 | -0.62 | -0.56 | -0.58 | -0.45 | -0.46 | -0.79 | -1.17 | -0.89 | -0.55 | -0.71 | -0.79 | -0.36 | -0.33 |
| Diluted Shares Outstanding | 71.48M | 64.23M | 63.85M | 63.79M | 63.67M | 54.9M | 54.9M | 54.73M | 50.97M | 44.45M | 44.36M | 44.27M | 37.67M | 27.8M | 27.22M | 27.08M | 24.23M | 21.28M | 21.27M | 10.5M |
| Basic Shares Outstanding | 71.48M | 64.23M | 63.85M | 63.79M | 63.67M | 54.9M | 54.9M | 54.73M | 50.97M | 44.45M | 44.36M | 44.27M | 37.67M | 27.8M | 27.22M | 27.08M | 24.23M | 21.28M | 21.27M | 10.5M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |